Chelsea Shareholders Lose Suit Over Drugmaker's Sale
The Delaware Chancery Court dismissed shareholder litigation Friday alleging Chelsea Therapeutics International Ltd.'s board acted in bad faith by omitting two projections from disclosures ahead of the drugmaker's 2014 sale, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article